Posted by Michael Wonder on 10 Dec 2019
FDA approves etectRx ‘digital pill’ as rivals struggle
10 December 2019 - The FDA has approved an ingestible event marker from the privately-held digital health company etectRx, as its rival “digital pill” company Proteus faces financial difficulties.
Florida-based etectRx said the ID-Cap system means this is the first device of its kind to transmit digital messages from within the body to an external receiver without need for direct skin contact.
The system consists of the ID-Capsule, a standard pharmaceutical capsule containing the ingestible sensor known as the ID-Tag.
